Clinical Trial Update: Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection

View source ↗

Summary

This update reports results from a Special Drug Use Investigation of fondaparinux (ARIXTRA) injection sponsored by GlaxoSmithKline; the study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thromboembolism | Status: COMPLETED